Remove common-pharma-interest a-guide-to-isolation-gown-selection
article thumbnail

Supporting Cell & Gene Therapy through Multimodal & Flexible Facilities

ISPE

This can require special manufacturing considerations less common in well-established biopharmaceuticals, such as enzymes or monoclonal antibodies (mAbs). Cell and gene therapies (C>) have unique needs in manufacturing suites that differ from those for classic product biopharmaceuticals. These considerations include processing safety (e.g.,

article thumbnail

Environmental Sustainability in Biopharmaceutical Facility Design

ISPE

From greener energy sources to a reduction in the type and amount of emissions, we are seeing improvement in this sector’s environmental footprint. 1 This view prioritizes steps that reduce the use of natural resources and the release of undesirable products such as carbon to the atmosphere or plastics to landfills. 7 An integrative (vs.